ENTITY
Bloomage Biotechnology  Lt

Bloomage Biotechnology Lt (688363 CH)

62
Analysis
Health CareChina
Bloomage Biotechnology Corporation Limited develops and manufactures medical products. The Company produces fillers, mesotherapy products, bio reactive hyaluronic acids, repair soothing skin care products, and other products. Bloomage Biotechnology supplies its products in medicine, cosmetics, food manufacturing companies, medical institutions, and other fields.
more
Refresh
11 Nov 2022 12:32

Shanghai/​​​​​​​​​​​​​​​​​​​​Shenzhen Northbound Connect: Weekly Moves (11 November 2022)

Overall, net inflow over the past week in the HK -Shanghai-Shenzhen Northbound Connect facilities was ~US$0.26bn, split between Shanghai...

Logo
360 Views
Share
bullishGiant Biogene
03 Nov 2022 09:50

Giant Biogene IPO Trading - Demand Was Relatively Better but Still Weak

Giant Biogene (GB) raised around US$70m by pricing its  HK IPO at the low-end. In this note we talk about the trading dynamics.

Logo
211 Views
Share
bullishGiant Biogene
26 Oct 2022 21:06

Pre-IPO Giant Biogene (2367 HK) - Some Unstable Factors

Giant Biogene's marketing-driven development will lead to low margins. It takes time for recombinant collagen to replace animal-derived collagen....

Logo
127 Views
Share
bullishGiant Biogene
25 Oct 2022 23:33

Giant Biogene IPO: Valuation Insights

The China A Share peers have derated due to the sharp sell-off in the last few days. Nevertheless, Biogene is attractively valued at the IPO price...

Logo
139 Views
Share
bullishGiant Biogene
25 Oct 2022 11:17

Giant Biogene IPO - Reasonable Valuation but in Unreasonable Markets

Giant Biogene is now looking to raise around US$80m in its Hong Kong IPO, down from its earlier target of US$500m raising.

Logo
212 Views
Share
x